Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Fosun Pharma sells 4.55% stake in Gland Pharma for Rs 2,121 crore
Chinese pharmaceutical major Fosun Pharma has pared its holding in Gland Pharma by selling a 4.5 per cent stake for Rs 2,121 crore through separate block deals on BSE. Fosun Pharma Industrial Pte Ltd, one of the promoters of Gland Pharma, offloaded…
Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA) Receives Average Recommendation of 'Moderate Buy' from Brokerages
Shares of Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA - Get Free Report) have received a consensus recommendation of 'Moderate Buy' from the six analysts that are currently covering the firm, MarketBeat Ratings reports. One research analyst has…
Trump's Drug Deals Are Working. Here's What Could Make Them Work Even Better.
President Donald Trump promised lower healthcare costs, and he's bringing lower healthcare costs. This week, Trump announced more voluntary deals with drug manufacturers under which they agreed to cut their U.S. prices to the rates they charge in…
3 Dividend Kings Built to Keep Raising Your Income When Rates Rise
Rising rates create a specific, mechanical problem for dividend stocks: when risk-free yields climb, a payout has to fight bonds for the same investor dollar, and share prices of income names often slide even when the underlying business is fine.
Two Sigma Securities LLC Purchases New Holdings in Eli Lilly and Company $LLY
Two Sigma Securities LLC purchased a new position in shares of Eli Lilly and Company (NYSE:LLY - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC).
From Africa to Ayurveda: a journey to healing in Cyprus
Miriam Erne is in what might be called a transitional phase. At 36, “I have lived through some stuff,” she says – vivid stuff and sometimes terrible stuff, images she'll carry with her to the end of her days. Right now…
Sigma Planning Corp Has $17.63 Million Stock Holdings in Eli Lilly and Company $LLY
Sigma Planning Corp trimmed its holdings in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 19.8% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 14,696 shares…
Eli Lilly and Company $LLY Stock Holdings Increased by NS Partners Ltd
NS Partners Ltd lifted its holdings in Eli Lilly and Company (NYSE:LLY - Free Report) by 77.4% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 28,723 shares of the company's…
Quantitative Investment Management LLC Decreases Stock Position in Eli Lilly and Company $LLY
Quantitative Investment Management LLC cut its holdings in Eli Lilly and Company (NYSE:LLY - Free Report) by 56.5% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional…
Wellington Management Group LLP Has $40.45 Million Stock Holdings in Zenas BioPharma, Inc. $ZBIO
Wellington Management Group LLP increased its holdings in shares of Zenas BioPharma, Inc. (NASDAQ:ZBIO - Free Report) by 27.9% in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned…
Bank of New York Mellon Corp Makes New Investment in Schrodinger, Inc. $SDGR
Bank of New York Mellon Corp acquired a new stake in Schrodinger, Inc. (NASDAQ:SDGR - Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The firm acquired 306,855 shares of the company's stock, valued…
Mutual Funds returns
EQUITY - LARGE & MID CAP FUNDS Bandhan Large & Mid Cap Fund HYBRID - AGGRESSIVE HYBRID FUNDS BOI AXA Mid & Small Cap Eq&Debt EQUITY - SMALL CAP FUNDS Bank of India Small Cap Fund HYBRID - BALANCED ADVANTAGE FUNDS Baroda BNP Paribas Balanced…
AXQ Capital LP Buys New Holdings in Vertex Pharmaceuticals Incorporated $VRTX
AXQ Capital LP purchased a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm purchased 2,797 shares of the pharmaceutical…
Here's how I lost 3 STONE in 3 WEEKS and it doesn't cost a penny
There comes a time in life when you look in the mirror and simply don't recognise the person staring back. In my mind, I'm still the fit and confident undercover TV reporter who posed bare-chested on the cover of the Radio Times in 1999 and ten…
What STAT readers think about M.D. vs. D.O., AI in medicine, surrogacy, and more
First Opinion is STAT's platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about…
Receive a Daily briefing on Pharma Industry News
Get Started